The Female Health Company  

(Public, NASDAQ:FHCO)   Watch this stock  
Find more results for FHCO
7.57
-0.07 (-0.92%)
After Hours: 7.57 0.00 (0.00%)
Apr 23, 5:09PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.55 - 7.74
52 week 6.65 - 10.21
Open 7.67
Vol / Avg. 80,395.00/90,008.00
Mkt cap 218.63M
P/E 17.73
Div/yield 0.07/3.70
EPS 0.43
Shares 28.88M
Beta 0.91
Inst. own 45%
May 1, 2014
Q2 2014 Female Health Co Earnings Release (Tentative) Add to calendar
Feb 3, 2014
Q1 2014 Female Health Co Earnings Conference Call
Feb 3, 2014
Q1 2014 Female Health Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 21.89% 45.59%
Operating margin 23.67% 31.12%
EBITD margin - 32.89%
Return on average assets 16.86% 43.72%
Return on average equity 19.36% 51.57%
Employees 132 -
CDP Score - -

Address

STE 2225, 515 NORTH STATE STREET
CHICAGO, IL 60610
United States - Map
+1-312-5959123 (Phone)
+1-312-5959122 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Female Health Company (FHC) manufactures, markets and sells the FC2 Female Condom (FC2). FC2 is the only available female-controlled product, approved by the U.S. Food and Drug Administration (FDA) and cleared by the World Health Organization (WHO) for purchase by U.N. agencies, that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including HIV/AIDS. FC2 is available in 143 countries. FC2 Female Condom provides women dual protection against STIs, including HIV/AIDS, and unintended pregnancy. Because FC2's primary usages are for disease prevention and family planning, the public health sector is the Company's main market. The Company operates in one industry segment, which includes the development, manufacture and marketing of consumer health care products.

Officers and directors

Overton B. Parrish Jr Chairman of the Board
Age: 79
Bio & Compensation  - Reuters
Karen L. King President, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Michele Greco Chief Financial Officer, Vice President
Age: 53
Bio & Compensation  - Reuters
Michael Pope Vice President - Global Manufacturing; General Manager of The Female Health Company (UK) Plc
Age: 55
Bio & Compensation  - Reuters
Janet Lee Controller
Age: 48
Bio & Compensation  - Reuters
William R. Gargiulo Jr. Secretary, Director
Age: 84
Bio & Compensation  - Reuters
Donna Felch Director
Age: 65
Bio & Compensation  - Reuters
David R. Bethune Independent Director
Age: 72
Bio & Compensation  - Reuters
Stephen M. Dearholt Independent Director
Age: 66
Bio & Compensation  - Reuters
Mary Margaret Frank Ph.D. Independent Director
Age: 43
Bio & Compensation  - Reuters